Electronic health records (EHRs); insurance claims; patient registries; wearable tech: Never before has health data been so abundant. However, the United States continues to struggle with siloed ...

Angela Jia, MD, PhD, is a radiation oncologist specializing in stereotactic body radiation therapy (SBRT), adaptive radiotherapy, and clinical trials focused on prostate, bladder, and kidney cancers.

The life sciences industry is at a turning point. The pressures are mounting—shorten development timelines, meet regulatory demands and deliver therapies that patients actually need in the real world.

Panelists discuss how RWE informs treatment and safety decisions for special populations such as patients with ECOG PS 2 with metastatic colorectal cancer. Panelists note that patients with ECOG ...

On December 17, the U.S. Food and Drug Administration (FDA) finalized its long-awaited guidance on the “Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices,” ...

Panelists discuss how future RWE should expand to include survival, quality of life, and safety data to improve third-line mCRC care. Panelists identify gaps in current evidence and the need for more ...

Benign prostatic hyperplasia (BPH) is one of the most common urologic conditions affecting men as they age, with nearly 50% of men over 50 experiencing symptoms. Despite its prevalence, treatment ...

Real-world data (RWD) is a powerful asset for pharmaceutical sponsors looking to enhance oncology trial design, support regulatory submissions, and demonstrate real-world value. From generating ...

In the largest real-world study of its kind with 428,707 patients, the Zio LTCM service outperformed other studied monitoring approaches in cardiac arrhythmia diagnostic yield, time to diagnosis, ...

WESTBOROUGH, Mass.--(BUSINESS WIRE)--Miach Orthopaedics, Inc., a company transforming the treatment of anterior cruciate ligament (ACL) tears with the BEAR® Implant, today announced the presentation ...

Suggested Citation: "3 Opportunities for Real-World Data." National Academies of Sciences, Engineering, and Medicine. 2017. Real-World Evidence Generation and Evaluation of Therapeutics: Proceedings ...

The traditional process for evaluating new therapeutics may not generate the evidence that patients, clinicians, and payers need to make real-world decisions. The volume and complexity of information ...